Shenzhen Oculgen Biomedical Technology

Shenzhen Oculgen Biomedical Technology is a clinical-stage biotechnology company dedicated to the development of advanced ophthalmic drug delivery systems. The company's core focus is on overcoming the challenges of frequent ocular injections through its proprietary sustained-release technology platforms, such as biodegradable implants and hydrogel-based delivery. Its lead candidates are designed to provide long-lasting treatment for chronic retinal diseases including wet age-related macular degeneration and glaucoma. By integrating material science with pharmaceutical innovation, Oculgen aims to significantly improve patient adherence and long-term visual health outcomes. The company is headquartered in Shenzhen, China, and has secured significant backing from prominent venture capital firms to advance its clinical pipeline.